Revance Therapeutics Revenue (TTM) Analysis

Revance Therapeutics Inc (RVNC)

5.78 -0.03 (-0.52%) USD | NASDAQ | Nov 07, 16:00

4.80 -0.98 (-16.96%) After-Hours: 07:56

Revenue (TTM) Chart

Historical Revenue (TTM) Data

View and export this data back to 2013. Upgrade now.

Date	Value
June 30, 2024	243.90M
March 31, 2024	232.92M
December 31, 2023	226.76M
September 30, 2023	206.88M
June 30, 2023	179.12M
March 31, 2023	153.08M
December 31, 2022	132.56M
September 30, 2022	108.59M
June 30, 2022	99.32M
March 31, 2022	89.76M
December 31, 2021	77.80M
September 30, 2021	62.98M
June 30, 2021	47.07M
March 31, 2021	28.57M
December 31, 2020	15.32M
September 30, 2020	4.281M
June 30, 2020	0.492M
March 31, 2020
December 31, 2019
September 30, 2019
June 30, 2019
March 31, 2019	3.813M

Date	Value
December 31, 2018	3.728M
September 30, 2018	3.278M
June 30, 2018	0.991M
March 31, 2018	0.38M
December 31, 2017	0.262M
September 30, 2017	0.30M
June 30, 2017	0.30M
March 31, 2017	0.30M
December 31, 2016	0.30M
September 30, 2016	0.30M
June 30, 2016	0.30M
March 31, 2016	0.30M
December 31, 2015	0.30M
September 30, 2015	0.30M
June 30, 2015	0.30M
March 31, 2015	0.30M
December 31, 2014	0.383M
September 30, 2014	0.617M
June 30, 2014	0.70M
March 31, 2014	0.70M
December 31, 2013	0.617M
September 30, 2013	0.425M

Revenues Definition

Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.

Read full definition.

Revenue (TTM) Range, Past 5 Years

0.492M

Minimum

Jun 2020

243.90M

Maximum

Jun 2024

112.32M

Average

99.32M

Median

Jun 2022

Revenue (TTM) Benchmarks